Literature DB >> 12700402

Quantitative changes in gene expression in fetal rat testes following exposure to di(n-butyl) phthalate.

Norman J Barlow1, Suzanne L Phillips, Duncan G Wallace, Madhabananda Sar, Kevin W Gaido, Paul M D Foster.   

Abstract

Di(n-butyl) phthalate (DBP) alters male reproductive development by decreasing testicular testosterone (T) production when fetuses are exposed on gestation days (GD) 12-21. Previous studies have shown altered gene expression for enzymes in the T biosynthetic pathway following exposure to DBP. The objectives of this study were to develop a more detailed understanding of the effect of DBP on steroidogenesis, using a robust study design with increased numbers of dams and fetuses, compared with previous studies, and to explore messenger RNA (mRNA) expression for other critical genes involved in androgen biosynthesis and signaling. Additionally, immunohistochemical localization of protein expression for several key genes was performed to further confirm mRNA changes. Fetal Leydig cell lipid levels were also examined histochemically, using oil red O. Six to seven pregnant Crl:CD(SD)BR rats per group were gavaged with corn oil or DBP at 500 mg/kg/day on GD 12-19. Testicular RNA isolated from three randomly selected GD 19 fetuses per litter was used for real-time RT-PCR for the following genes: scavenger receptor class B-1 (SRB1), steroidogenic acute regulatory protein (StAR), P450 side-chain cleavage enzyme (P450scc), 3beta-hydroxysteroid dehydrogenase (3beta-HSD), P450c17, 17beta-hydroxysteroid dehydrogenase (17beta-HSD), androgen receptor (AR), luteinizing hormone receptor (LHR), follicle-stimulating hormone receptor (FSHR), stem cell factor tyrosine kinase receptor (c-kit), stem cell factor (SCF), proliferating cell nuclear antigen (PCNA), and testosterone-repressed prostate message-2 (TRPM-2). mRNA expression was downregulated for SRB1, StAR, P450scc, 3beta-HSD, P450c17, and c-kit following DBP exposure, and TRPM-2 was upregulated. 17beta-HSD, AR, LHR, FSHR, and PCNA were not significantly changed. Immunohistochemical staining for c-kit was seen in fetal Leydig cells, which has not been previously reported. Downregulation of most of the genes in the T biosynthetic pathway confirms and extends previous findings. Diminished Leydig cell lipid content and alteration of cholesterol transport genes also support altered cholesterol metabolism and transport as a potential mechanism for decreased T synthesis following exposure to DBP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700402     DOI: 10.1093/toxsci/kfg087

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  48 in total

1.  Comparison of toxicogenomic responses to phthalate ester exposure in an organotypic testis co-culture model and responses observed in vivo.

Authors:  Sean Harris; Sanne A B Hermsen; Xiaozhong Yu; Sung Woo Hong; Elaine M Faustman
Journal:  Reprod Toxicol       Date:  2015-10-22       Impact factor: 3.143

2.  Improving in vitro Sertoli cell/gonocyte co-culture model for assessing male reproductive toxicity: Lessons learned from comparisons of cytotoxicity versus genomic responses to phthalates.

Authors:  Xiaozhong Yu; Sungwoo Hong; Estefania G Moreira; Elaine M Faustman
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-26       Impact factor: 4.219

3.  Characterization of bovine fetal Leydig cells by KIT expression.

Authors:  Nikoloz Tsikolia; Claudia Merkwitz; Kristina Sass; Michiharu Sakurai; Katharina Spanel-Borowski; Albert Markus Ricken
Journal:  Histochem Cell Biol       Date:  2009-09-19       Impact factor: 4.304

4.  Fungal biodegradation of dibutyl phthalate and toxicity of its breakdown products on the basis of fungal and bacterial growth.

Authors:  M Ahuactzin-Pérez; J L Torres; B R Rodríguez-Pastrana; J Soriano-Santos; G Díaz-Godínez; R Díaz; S Tlecuitl-Beristain; C Sánchez
Journal:  World J Microbiol Biotechnol       Date:  2014-07-26       Impact factor: 3.312

5.  A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and semen quality in men with inflammatory bowel disease.

Authors:  Feiby L Nassan; Brent A Coull; Niels E Skakkebaek; Michelle A Williams; Ramace Dadd; Lidia Mínguez-Alarcón; Stephen A Krawetz; Elizabeth J Hait; Joshua R Korzenik; Alan C Moss; Jennifer B Ford; Russ Hauser
Journal:  Environ Int       Date:  2016-08-26       Impact factor: 9.621

6.  DEHP reduces thyroid hormones via interacting with hormone synthesis-related proteins, deiodinases, transthyretin, receptors, and hepatic enzymes in rats.

Authors:  Changjiang Liu; Letian Zhao; Li Wei; Lianbing Li
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-28       Impact factor: 4.223

7.  Genome-wide DNA methylation profiling of CpG islands in hypospadias.

Authors:  Shweta Choudhry; Archana Deshpande; Liang Qiao; Kenneth Beckman; Saunak Sen; Laurence S Baskin
Journal:  J Urol       Date:  2012-08-17       Impact factor: 7.450

8.  Transcriptional biomarkers of steroidogenesis and trophoblast differentiation in the placenta in relation to prenatal phthalate exposure.

Authors:  Jennifer J Adibi; Robin M Whyatt; Russ Hauser; Hari K Bhat; Barbara J Davis; Antonia M Calafat; Lori A Hoepner; Frederica P Perera; Deliang Tang; Paige L Williams
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

9.  Effects of endocrine disrupting chemicals on expression of phospholipid hydroperoxide glutathione peroxidase mRNA in rat testes.

Authors:  In Jeoung Baek; Jung Min Yon; Se Ra Lee; Yan Jin; Mi Ra Kim; Byeongwoo Ahn; Jin Tae Hong; Young Kug Choo; Beom Jun Lee; Young Won Yun; Sang Yoon Nam
Journal:  J Vet Sci       Date:  2007-09       Impact factor: 1.672

10.  Time- and dose-related effects of di-(2-ethylhexyl) phthalate and its main metabolites on the function of the rat fetal testis in vitro.

Authors:  François Chauvigné; Arnaud Menuet; Laurianne Lesné; Marie-Christine Chagnon; Cécile Chevrier; Jean-François Regnier; Jürgen Angerer; Bernard Jégou
Journal:  Environ Health Perspect       Date:  2008-12-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.